6472.TW
6472.TW
TW0006472004
BORA PHARMACEUTICALS CO LTD
Loading chart...

Company Profile

Bora Pharmaceuticals Co., LTD. engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally. The company operates through Sales, CDMO, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services and technical services for the development of pharmaceutical products. In addition, it provides Western pharmaceuticals, including central nervous system medications, antibiotics, and gastrointestinal medications; and nutritional and vitamin supplements, physical recovery, and health care products. The company sells its products directly to clinics, pharmacies, pharmacy chains, and drug stores, as well as through distributors to medical centers, corporate and public hospitals, and regional and district hospitals. Bora Pharmaceuticals Co., LTD. was incorporated in 2007 and is based in Taipei City, Taiwan.

Related stocks

1795.TW
1795.TW • Taiwan
LOTUS PHARMACEUTICAL CO
180.5 TWD
1.5B USD 1Y -35%
4540.T
4540.T • Japan
TSUMURA & CO
3,772 JPY
1.78B USD 1Y +5%
1681.HK
1681.HK • China
CONSUN PHARMA
14.85 HKD
1.59B USD 1Y -13.6%
4123.TWO
4123.TWO • Taiwan
CENTER LABORATORIES INC
31.35 TWD
735.36M USD 1Y -5.4%
JUBLPHARMA.BO
JUBLPHARMA.BO • India
JUBILANT PHARMOVA LIMITED
931.2 INR
1.52B USD 1Y -14.2%
603707.SS
603707.SS • China
NANJING KING-FRIEND BIOCHEMICAL
8.18 CNY
1.98B USD 1Y -21.6%
CAPLIPOINT.BO
CAPLIPOINT.BO • India
CAPLIN POINT LABORATORIES LTD.
2,459.55 INR
1.93B USD 1Y +27.1%
4516.T
4516.T • Japan
NIPPON SHINYAKU CO
3,372 JPY
1.44B USD 1Y -0.4%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
47.4% p.a.
Max Drawdown (5Y)
-57.8%
Sharpe Ratio (5Y)
0.51
Beta Factor
0.44
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (47.4% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -61.1% in the extended horizon.
ende